KG
LLY icon

Kilter Group’s Eli Lilly LLY Stock Holding History

Kilter Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$344K Buy
287
+19
+7% +$19.4K 0.12% 45
2026
Q1 		$246K Sell
268
-92
-26% -$93.3K 0.11% 51
2025
Q4 		$387K Buy
360
+273
+314% +$261K 0.17% 44
2025
Q3 		$66.4K Buy
87
+3
+4% +$2.23K 0.03% 87
2025
Q2 		$65.5K Buy
+84
New +$65.3K 0.03% 84

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Kilter Group's LLY Position: Q2 2026 in Review

Kilter Group increased its Eli Lilly (LLY) stake by 7.1% in Q2 2026, buying an estimated $19.4K and bringing the position to 287 shares worth $344K. The position accounts for 0.12% of the portfolio, ranked #45.

Kilter Group first reported a position in LLY in Q2 2025 and has held it in 5 quarters since. The position peaked at $387K in Q4 2025. 4,614 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Kilter Group held 287 shares of Eli Lilly worth $344K as of Q2 2026.
  • Kilter Group bought 19 Eli Lilly shares in Q2 2026, an estimated $19.4K.
  • Eli Lilly made up 0.12% of Kilter Group's portfolio in Q2 2026, its #45 holding.
  • Kilter Group first reported a position in Eli Lilly in Q2 2025 and has held it in 5 quarters since.
  • Kilter Group's Eli Lilly position peaked at $387K in Q4 2025.
  • 4,614 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Kilter Group's 13F filing for Q2 2026, filed 11 Aug 2026.